Latest posts tagged with #hemonc on Bluesky
#Jacksonville! Join Drs. Advani Pooja, Julio Chavez, Bruna Pellini, Hani Babiker, and more, for practice-changing clinical data and expert recommendations to optimize outcomes for patients with hematologic malignancies. Register NOW: binaytara.org/projects/con... #CMEConference #Binaytara #HemOnc
Prolonged endurance #running may impact #redBloodCells, with signs associated with accelerated #RBC aging observed with ultra-running. Published in @bloodjournals.hematology.org.
https://bit.ly/4dmpsfg
#HemOnc
We're thrilled to be an official media partner for #EBMT26, and we can't wait to be on-site once again, filming our expert video interviews! 🎥🩸
Interested in joining us there or attending virtually?
Click here to register now:
➡️ buff.ly/bWxuru2
#BMTsm #HemOnc #ImmunoOnc @theebmt.bsky.social
🩸Facts about Multiple Myeloma:
Myeloma Biology and Microenvironment
#MultipleMyeloma #Hematology #NKcells #Cytogenetics #HEMEHUB #TP53 #NFkB #Hyperdiploidy #t1114 #del17p #HemOnc #MedEd
Want to find out about the latest updates and advances in transplantation and cellular therapy?🩸
Then you won't want to miss the 52nd Annual Meeting of the EBMT taking place 22–25 March in Madrid, Spain, & online.🇪🇸💻
Register here:
➡️ buff.ly/0fBo0ka
#EBMT26 #HemOnc #BMTsm @theebmt.bsky.social
🩸Facts about Multiple Myeloma:
Frontline Integration
#MultipleMyeloma #Hematology #BispecificAntibodies #StemCellTransplant #ASCT #BsAbs #MRD #ClinicalTrials #Elranatamab #Teclistamab #MajesTEC4 #MajesTEC5 #HemOnc #HEMEHUB
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer 2026, Boise: binaytara.org/projects/con... #HemOnc #CMEConference #Medsky
🩸 Additional insights on adverse events and management in Multiple Myeloma
#MultipleMyeloma #BCMA #GPRC5D #BispecificAntibodies #BsAbs #Immunotherapy #PlasmaCells #IVIG #Oncology #HemOnc #Hematology #ClinicalTrials #MajesTEC3 #HEMEHUB
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer 2026, Boise: binaytara.org/projects/con... #HemOnc #CMEConference #Medsky
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer Conference 2026 in Baton Rouge, LA: binaytara.org/projects/con... #HemOnc #CMEConference #Medsky
Join us at the CME/MOC/ACPE-accredited Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026: binaytara.org/projects/con... #CMEConference #Medsky #HemOnc
Efanesoctocog alfa has been successfully integrated into clinical practice for treating severe #hemophilia A, including patients previously excluded from trials, such as those with FVIII inhibitors or prior emicizumab use. From @rarediseaseadvisor.bsky.social.
https://bit.ly/4k5pkCc
#hemonc
🤝Honored to partner with the United Porphyrias Association to advance education, awareness, and support for patients living with rare porphyrias. Looking forward to fostering a meaningful impact together.
🌍Stay connected: hemehub.org
#RareDisease #UPA #Porphyria #HemOnc #MedEd #Hematology #HemeHub
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer 2026, Boise: buff.ly/9jFgCuq #HemOnc #CMEConference #Medsky
“These findings align with prior mechanistic research demonstrating increased CNI-related #cancerrisk and represents novel comparative safety data between these treatment modalities,” @jeffsparks.bsky.social of @harvardmed.bsky.social wrote.
https://bit.ly/4bqSrhm
#HemOnc
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer Conference 2026 in Baton Rouge, LA: binaytara.org/projects/con... #HemOnc #CMEConference #Medsky
Just one week to go until #CART26 kicks off in Palma de Mallorca, Spain, and online!🇪🇸 💻
Hear from the meeting chair, Annalisa Ruggeri, who encourages you to register for this hybrid meeting:
🎥 buff.ly/poXdp9x
Register here:
➡️ buff.ly/LMXQ0qU..
#CARTCell #ImmunoOnc #HemOnc @theebmt.bsky.social
🩸🔬Today's question!
See the answer and explanation on the next slide.
#MultipleMyeloma #NDMM #AutologousStemCellTransplant #ASCT #VRd #GMMGHD7 #MRDNegativity #ClinicalTrials #Hematology #HemOnc #MedEd
🩸Facts about Multiple Myeloma:
Bispecific Antibodies (BsAbs) – Mechanism and Approval
#MultipleMyeloma #RRMM #Hematology #HemOnc #BispecificAntibodies #BsAbs #Immunotherapy #CD3 #BCMA #Teclistamab #Elranatamab #Linvoseltamab #MedEd
Join us at the CME/MOC/ACPE-accredited Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026: binaytara.org/projects/con... #CMEConference #Medsky #HemOnc
A new point-of-care platform is gaining attention as a promising tool to improve #coagulation testing for people with #hemophilia A. From @rarediseaseadvisor.bsky.social.
https://bit.ly/462BmXm
#HemOnc
🩸Proud to announce our partnership with Texas Oncology.
🤝🩺Together, we aim to advance education in #hematology and #oncology, support meaningful learning for clinicians, and ultimately improve clinical outcomes for patients.
🌍Stay connected: hemehub.org
#HemOnc #BloodDisorders #MedEd #HemeHub
Patients with #bloodcancer eligible for #hospice care emphasize the importance of access to #transfusion over other services. Published in @jamanetworkopen.com.
https://bit.ly/4k6hl8d
#HemOnc
📅 Plan your year in #hemOnc! To help you stay aware of events relevant to #hematology professionals, here is the 2026 calendar for various professional meetings and conferences.
View the full list here: 🩸 https://bit.ly/3NoRnk6
#MedicalConferences
ExPeCT™ anti‑CD19 (FMC63) CAR T qPCR gives clinicians the visibility they’ve been missing.
Talk to us in person at Booth# 511.
#HemOnc #CARTcell #ExPeCTViracor
Join Dr. Swathi Namburi, Aaron Boothby, and Dr. Hannah Linden at #WAHemBreast26 on Jan 17. Register TODAY: buff.ly/dhO9yho #Medsky #HemOnc #BreastCancer #CMEConference
Join Dr. Vivian G Oehler and Dr. Chaitra Ujjani at #WAHemBreast26 on Jan 17. Register TODAY: buff.ly/dhO9yho #Medsky #HemOnc #BreastCancer #CMEConference
Join Dr. Fengting Yan and Dr. Roland Walter at #WAHemBreast26 on Jan 17. Register TODAY: buff.ly/dhO9yho #Medsky #HemOnc #BreastCancer #CMEConference
From AI to mRNA vaccines, this year delivered breakthroughs that are reshaping how we detect, treat, and think about cancer. As innovation progresses, oncologists face challenges around equity, access, and implementing these advancements in real-world contexts: buff.ly/FHcGn0g #HemOnc
